Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Contineum Therapeutics, Inc. | General Counsel and Corp Sec | Stock Option (right to buy) | 160K | Jun 3, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CTNM | Contineum Therapeutics, Inc. | Jun 3, 2024 | 1 | $0 | 4 | Jun 3, 2024 | General Counsel and Corp Sec |
CTNM | Contineum Therapeutics, Inc. | May 30, 2024 | 0 | $0 | 3 | Jun 3, 2024 | General Counsel and Corp Sec |
TYRA | Tyra Biosciences, Inc. | Mar 1, 2022 | 0 | $0 | 3 | Mar 3, 2022 | General Counsel and Secretary |